 Tom Jones |
Tom Jones, who headed Ketchum's North American health practice, has joined independent shop Finn Partners as head of the health & wellness practice.
He reports to Kristie Kuhl, US pharma chief and managing partner of the New York and Chicago health groups.
Jones will spearhead Finn's patient activation effort. Kuhl called "enabling consumers to have a voice in their health experience" one of the biggest challenges facing the sector.
Prior to Ketchum, Jones led Makovsky's health unit and worked as executive director of communications for the primary care division of Novartis.
Binaytara, the Bellevue, WA-based nonprofit dedicated to improving access to cancer care and fostering scientific research, has appointed FINN Partners as its global PR firm.
Jeffrey Sturchio is joining Finn Partners’ health policy and impact group as senior advisor to counsel clients on the issues shaping global health and innovation access.
A breakthrough is not successful merely because it works. It succeeds when people and health systems can actually use it.
Jim Weiss, founder & chairman of Real Chemistry, has joined the board of ICR Inc. as it steps up its healthcare capital markets offering.
Ruder Finn has hired Kelly Yoder, who spent a dozen years at Weber Shandwick rising to North America health lead, as managing director, global head of health & life sciences.
